RS

Rajamohanan Sreedharan Pillai

Active Director Director DIN 11467657
DIN 11467657 First appointment Jan 2026 Primary industry Ecommerce and Internet
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajamohanan Sreedharan Pillai

Data last updated:

Rajamohanan Sreedharan Pillai is a Director at Heilmed Healthcare Products Private Limited (since 2026). The company operates in Ecommerce and Internet.

DIN 11467657
Primary Designation Director
Industry Ecommerce and Internet
First Appointment 06 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jan 20262026Active

Board colleagues of Rajamohanan Sreedharan Pillai

Directorship timeline

Open interactive timeline →
Heilmed Healthcare Products Private Limited
Premium access

Shareholding and investment profile for Rajamohanan Sreedharan Pillai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajamohanan Sreedharan Pillai

Rajamohanan Sreedharan Pillai currently holds 1 directorship: Heilmed Healthcare Products Private Limited (Director, since 06 Jan 2026).

Rajamohanan Sreedharan Pillai was first appointed on 06 Jan 2026 as Director at Heilmed Healthcare Products Private Limited.

The current boards of Rajamohanan Sreedharan Pillai's companies include Lethakumari Rajamohanan (Heilmed Healthcare Products Private Limited), Rahul Raj Menon (Heilmed Healthcare Products Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available